|
private:ambys
|
33226533
|
Apr 21st, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 21st, 2024 05:05AM
|
Apr 21st, 2024 05:05AM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 20th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 20th, 2024 04:05AM
|
Apr 20th, 2024 07:23PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 19th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 19th, 2024 06:27AM
|
Apr 19th, 2024 06:27AM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 18th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 18th, 2024 05:08AM
|
Apr 18th, 2024 08:43PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 17th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 17th, 2024 06:27AM
|
Apr 17th, 2024 05:11PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 16th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 16th, 2024 03:51AM
|
Apr 16th, 2024 01:28PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 15th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 15th, 2024 06:47AM
|
Apr 15th, 2024 07:09PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 14th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 14th, 2024 02:33AM
|
Apr 14th, 2024 02:33AM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 13th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 13th, 2024 01:34AM
|
Apr 13th, 2024 01:52PM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|
|
private:ambys
|
33226533
|
Apr 12th, 2024 12:00AM
|
Ambys Medicines
|
5.2K
|
18.00
|
Open
|
|
Apr 12th, 2024 01:45AM
|
Apr 12th, 2024 10:54AM
|
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
|
Open
|
|
Open
|
131 Oyster Point Blvd
|
South San Francisco
|
California
|
US
|
94080
|
|
Ambys Medicines
|
|
|